Adam Torres and Suren Ajjarapu discuss The PIPEs Conference.
Subscribe: iTunes / Spotify
Apply to be a guest on our podcast here
Show Notes:
Listen to The PIPEs Conference coverage. In this episode, Adam Torres interviews Suren Ajjarapu, Chairman & CEO at Scienture Holdings, Inc (NASDAQ: SCNX), explore Scienture Holdings, Inc and The PIPEs Conference.
Watch Full Interview:
Full Unedited Transcript
Hey, I’d like to welcome you to another episode of Mission Matters. My name is Adam Torres, and today I am at the Hard Rock Casino in Hollywood, Florida. We’re at the Pipes Conference, a deal flow event, and we’re going to have a whole lot of fun. So today my guest is Surin. So Surin, welcome to the show.
Thanks Adam. All right. So first off, what brings you out to the conference? So Pipe Conference, we’re in the process of raising money for our company ticker symbol, SCNX, Sam Charlie, Nancy Xerox. We’re in biotech form trying to raise the pipe money. And so that’s why I’m here. Awesome. So is this your first time to a deal flow event?
Second, the first one is at Atlantic city. Yeah. And a little bit of knowledge for the, for the audience. So how did I get certain on the show? He helped me come in, man. I was, I was, I was lost in the lobby. I think he felt bad. He’s like this lost sheep over here. He says, where is he at? How’s he going to get there?
So yeah, no, all good there. Tell, tell us a little bit more about your company. Yeah. As I mentioned, originally it’s a biotech company. We have three molecules that are coming into play. We are a 505 B2 kind of a structuring company. The management team built several biotech companies before. And we have an SN102 that market size of 60 million prescriptions.
And we’re trying to bring in a liquid version of that. And SN 104, it’s another 505B2, and the third one I have a biosimilars. So our market cap is very low before we launch our molecules. So we’re at the verge of marketing these molecules next year. Tell me a little bit more about your background and how you got started in this.
Perfect, Adam. Thank you. I’m mostly a finance guy. I’ve been in the pharma industry since 2010. I’ve taken almost like six companies to public. Three of them are SPACs. O. C. E. A. T. V. G. N. And this is the third one. S. C. N. X. The previously before the S. C. N. X. The meds used to be the my ticker symbol. I’ve given a lot of shareholder value.
And given the dividends, almost like 8 a share, given the dividend. What attracted you to this latest company in this latest project? Like what was so special? A lot, a lot of, with your background, taking companies public, a lot of different things you could have done a lot of projects. What drew you in? This has driven me for drive me towards launching the molecules.
Other biotech companies, you have to wait for four to five years. I am entering into this last stage and they’re ready to commercialize the product. So they’ve already spent four or five years into this and I’m coming at the cusp of launching and taking the fruits out of that. Hold on, so you’re coming out of the tail end, now you have to take it to the finish line, right?
Yes. Yeah. So what do you hope to get out of the conference today? A lot of networking mostly understanding the pipe structures. So I’m in the still process of continue to raise additional capital. That’s the reason I’m here. Yeah, this is, and this is my first, so I’ve done conferences virtually for deal flow, but I haven’t been to one in person.
So what do you think so far? I’m walking around, I’m like this amazing hard rock casino. I never been to this one. I don’t know. What do you think so far? I hope you came to the night, the networking event or not. I missed that one. I was a little, I had another engagement, but was it good? Yeah, that was good interaction.
I think everybody. Seemed with the elections and stuff, everybody showed up almost like a thousand people showed up yesterday. Wow. So everybody’s ready to finally be like, okay, we can move again. We can like, we’re, we’re back in that’s what they’re all for. Awesome. So sir, and any notable announcements or things coming up with your company that you care to share that you can share right now, like as we kind of wrap this up, I just want to subvert the potential investors out there for the potential, you know, keep looking at, keep watching our stock.
Because there are some catalysts that are coming out there and you can something in the pipeline. Yeah. Awesome. Final thing, Surin, if somebody wants to follow up, they want to learn more, of course, that ticker one more time, but also website and otherwise, how do they get information? Sure. Sanchur.
com. S C I E N T U R E. com. Ticker symbol, Sam, Charlie, Nancy, Xerox. SCNX. Fantastic. And for everybody watching, just so you know, we’ll put links to that in the show notes, so you can just click on the link and head right on over. And if this is your first time with mission matters and you haven’t done it yet, make sure you hit that subscribe or follow button.
This is a daily show each and every day. We’re bringing you new content, new ideas, and hopefully new investment ideas to help you along the way on your journey as well. Again, hit that subscribe or follow button and CERN. Thanks again for coming on. Thanks a lot, Adam. Appreciate that.